Recombinant SuperCompound Interferon

天然复合干扰素-α（基康生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant SuperCompound Interferon
Drug Alias Nameinterferon α-con
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Xinshengyuan Biological Medicine Co LtdShanghai Genecore Biotechnologies Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Xinshengyuan Biological Medicine Co LtdShanghai Sisheng Enterprise Management Consulting Co LtdShanghai Genecore Biotechnologies Co Ltd
Active IndicationsN/A
Inactive IndicationsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A